Will inhalational GM-CSF replace whole lung lavage as a treatment for autoimmune pulmonary alveolar proteinosis? Many pole positions, not yet the final winner.

Bonella, Francesco; Manali, Effrosyni D; Papiris, Spyros A

Bonella, Francesco; Manali, Effrosyni D; Papiris, Spyros A.

Affiliation

Bonella F; Center for interstitial and rare lung diseases, Pneumology Department, Ruhrlandklinik University Hospital, University of Duisburg-Essen, Essen, Germany Francesco.bonella@rlk.uk-essen.de.
Manali ED; 2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Papiris SA; 2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Eur Respir J ; 63(1)2024 01.

Article in En | MEDLINE | ID: mdl-38176702

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Alveolar Proteinosis Limits: Humans Language: En Journal: Eur Respir J Year: 2024 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google